Intranasal exosomes for treatment of neuroinflammation?: Prospects and limitations

Molecular Therapy

Volumn 19, Issue 10, 2011, Pages 1754-1756

  Lakhal, Samira ^a   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL THERAPY AGENT; CHOLINERGIC RECEPTOR; CURCUMIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDE; ONCOLYTIC VIRUS; PROTEIN INHIBITOR; STAT3 PROTEIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALZHEIMER DISEASE; APOPTOSIS; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BONE MARROW CELL; BRAIN DISEASE; CELL FUNCTION; CELL HOMING; CELL KINETICS; CELL MOTILITY; CELL TRANSFER; CELL TRANSPORT; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; EXOSOME; GLIOBLASTOMA; HEART PROTECTION; HUMAN; IN VIVO STUDY; MACROPHAGE; MICROGLIA; MIGRAINE; MONOTHERAPY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NOSE CAVITY; NOTE; PARKINSON DISEASE; PARTICLE SIZE; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; REPERFUSION INJURY; SCHIZOPHRENIA; T LYMPHOCYTE; TARGET CELL; THERAPY DELAY; THERAPY EFFECT; TRANSCRIPTOMICS; TRANSLATIONAL RESEARCH; TREATMENT DURATION; VIRUS ENCEPHALITIS;

EID: 80053497622     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.198     Document Type: Note

References (12)

1. Zhuang, X, Xiang, X, Grizzle, W, Sun, D, Zhang, S, Axtell, RC et al. (2011). Treatment of brain inflammatory diseases by delivering exosomeencapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19: 1769-1779.
2. Valadi, H, Ekstrom, K, Bossios, A, Sjostrand, M, Lee, JJ and Lötvall, JO (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659. (Pubitemid 47214727)
3. Nazarenko, I, Rana, S, Baumann, A, McAlear, J, Hellwig, A, Trendelenburg, M et al. (2010). Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70: 1668-1678.
4. Lotvall, J and Valadi, H (2007). Cell to cell signalling via exosomes through esRNA. Cell Adh Mig 1: 156-158.
5. Fevrier, B and Raposo, G (2004). Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16: 415-421. (Pubitemid 38903148)
6. Schorey, JS and Bhatnagar, S (2008). Exosome function: from tumor immunology to pathogen biology. Traffic 9: 871-881. (Pubitemid 351639493)
7. Alvarez-Erviti, L, Seow, Y, Schapira, AH, Gardiner, C, Sargent, IL, Wood, MJ et al. (2011). Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42: 360-367.
8. Lai, RC, Arslan, F, Lee, MM, Sze, NS, Choo, A, Chen, TS et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4: 214-222.
9. Alvarez-Erviti, L, Seow, Y, Yin, H, Betts, C, Lakhal, S and Wood, MJ (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29: 341-345.
10. Sun, D, Zhuang, X, Xiang, X, Liu, Y, Zhang, S, Liu, C et al. (2010). A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18: 1606-1614.
11. Record, M, Subra, C, Silvente-Poirot, S and Poirot, M (2001). Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81: 1171-1182.
12. Thorne, RG, Pronk, GJ, Padmanbhan, V, Frey, WH 2nd (2004). Delivery of insulin-like growth factor-I to the rat brain and spinal cord along the olfactory and trigeminal pathways following intranasal administration. Neuroscience 127: 481-496. (Pubitemid 38950662)